StockData
ADC Therapeutics SA logo

ADC Therapeutics SA (ADCT) stock

ADCTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$1.35+0.10 (+8.00%)

Close on Nov 17, 2026Market cap $172.35MP/E –Yield –

ADC Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

ADC Therapeutics's price to book ratio was 4.1× on Jul 31, 2023.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Jul 31, 20234.1×−1.7
2022Apr 29, 20225.9×–

More ADC Therapeutics figures

See a number that looks wrong?